Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signaling

Direct targeting of the downstream MAPK pathway to suppress ERK activation in KRAS and BRAF mutant colorectal cancer (CRC) has proven clinically unsuccessful, but promising results have been obtained with combination therapies including EGFR-inhibition. To elucidate the interplay between EGF signali...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponsioen, Bas, Post, Jasmin B., des Amorie, Julian R. Buissant, Laskaris, Dimitrios, van Ineveld, Ravian L., Kersten, Simone, Bertotti, Andrea, Sassi, Francesco, Sipieter, François, Cappe, Benjamin, Mertens, Sander, Verlaan-Klink, Ingrid, Boj, Sylvia F., Vries, Rob G.J., Rehmann, Holger, Vandenabeele, Peter, Riquet, Franck B., Trusolino, Livio, Bos, Johannes L., Snippert, Hugo J.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610573/
https://www.ncbi.nlm.nih.gov/pubmed/33795873
http://dx.doi.org/10.1038/s41556-021-00654-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610573/
https://www.ncbi.nlm.nih.gov/pubmed/33795873
http://dx.doi.org/10.1038/s41556-021-00654-5

Ejemplares similares